NASDAQ$BTTC

Black Titan Corp · Q2 2013 earnings

Q2 2013 earnings · Reported Aug 14, 2013 (13 years ago) · Investor relations

Aug 14Jun 30, 2013

Total Revenue

-$120K

Previous: $1.36M-108.8%

EPS (adj)

$1.80

Previous: -$0.60+400.0%

Capital Expenditures

$118K

Previous: $467K-74.7%

Free Cash Flow

-$3.93M

Previous: -$3.12M-25.8%

Net Income

-$102K

Previous: -$1.72M+94.1%

Operating Income

$30K

Previous: -$1.74M+101.7%

Gross Profit

$507K

Previous: $1.36M-62.7%

Cash & Equivalents

$288K

Previous: $4.1M-93.0%

Total Assets

$7.78M

Previous: $10.1M-22.6%

Stock-Based Comp

$130K

Previous: $316K-58.9%

Titan Pharmaceuticals · Revenue · Quarterly

-$120K

Q2 2013-108.8%vs Q2 2012

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation